BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113:175-194. [PMID: 29336434 DOI: 10.1038/ajg.2017.469] [Cited by in Crossref: 205] [Cited by in F6Publishing: 176] [Article Influence: 51.3] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Cui J, Chen AH, Zong ZM, Wei XY. Optimization of Ultrasonic-Microwave Assisted Extraction and Hepatoprotective Activities of Polysaccharides from Trametes orientalis. Molecules 2019;24:E147. [PMID: 30609723 DOI: 10.3390/molecules24010147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
2 Zelman, S. M.H., Erik MD1; Malik, Raza MD1; Dickstein, Aaron MD, Alcoholic Hepatitis and COVID-19: The Question of Steroids.ACG Case Rep J. 2020;7:e00504. [DOI: 10.14309/crj.0000000000000504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Jones BE, Allegretti AS, Pose E, Mara KC, Ufere NN, Avitabile E, Shah VH, Kamath PS, Ginès P, Simonetto DA. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci 2021. [PMID: 33604793 DOI: 10.1007/s10620-021-06864-z] [Reference Citation Analysis]
4 Zhao N, Xia G, Cai J, Li Z, Lv X. Adenosine receptor A2B mediates alcoholic hepatitis by regulating cAMP levels and the NF-KB pathway. Toxicology Letters 2022. [DOI: 10.1016/j.toxlet.2022.01.012] [Reference Citation Analysis]
5 Singal AK, Kamath PS. Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. Transl Gastroenterol Hepatol 2019;4:74. [PMID: 31728431 DOI: 10.21037/tgh.2019.09.11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
6 Licata A, Zerbo M, Como S, Cammilleri M, Soresi M, Montalto G, Giannitrapani L. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement? Nutrients 2021;13:4014. [PMID: 34836267 DOI: 10.3390/nu13114014] [Reference Citation Analysis]
7 Strauss R, Cressman A, Cheung M, Weinerman A, Waldman S, Etchells E, Zahirieh A, Tartaro P, Rezmovitz J, Callum J. Major reductions in unnecessary aspartate aminotransferase and blood urea nitrogen tests with a quality improvement initiative. BMJ Qual Saf 2019;28:809-16. [PMID: 31073091 DOI: 10.1136/bmjqs-2018-008991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
8 Novo-Veleiro I, Herrera-Flores J, Rosón-Hernández B, Medina-García JA, Muga R, Fernández-Solá J, Martín-González MC, Seco-Hernández E, Suárez-Cuervo C, Mateos-Díaz AM, Monte-Secades R, Machado-Prieto B, Puerta-Louro R, Prada-González C, Fernández-Rial Á, Sabio-Repiso P, Vázquez-Vigo R, Antolí-Royo AC, Gomila-Grange A, Felipe-Pérez NC, Sanvisens-Bergé A, Antúnez-Jorge E, Fernández-Rodríguez CM, Alvela-Suárez L, Fidalgo-Navarro A, Castro J, Polvorosa-Gómez MA, Del Valle-Sánchez M, López-Castro J, Chamorro AJ, Marcos M; Wernicke-SEMI Group, Alcohol and Alcoholism Group, Spanish Society of Internal Medicine (SEMI). Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study. Drug Alcohol Depend 2022;230:109186. [PMID: 34864357 DOI: 10.1016/j.drugalcdep.2021.109186] [Reference Citation Analysis]
9 Zhu Z, Zhou W, Yang Y, Wang K, Li F, Dang Y. Quantitative Profiling of Oxylipin Reveals the Mechanism of Pien-Tze-Huang on Alcoholic Liver Disease. Evid Based Complement Alternat Med 2021;2021:9931542. [PMID: 34158817 DOI: 10.1155/2021/9931542] [Reference Citation Analysis]
10 Ayuso P, García-Martín E, Cornejo-García JA, Agúndez JAG, Ladero JM. Genetic Variants of Alcohol Metabolizing Enzymes and Alcohol-Related Liver Cirrhosis Risk. J Pers Med 2021;11:409. [PMID: 34068303 DOI: 10.3390/jpm11050409] [Reference Citation Analysis]
11 Shirai D, Shinkawa H, Takemura S, Tanaka S, Amano R, Kimura K, Kinoshita M, Kawada N, Kubo S. Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease. Ann Med Surg (Lond) 2021;68:102644. [PMID: 34386231 DOI: 10.1016/j.amsu.2021.102644] [Reference Citation Analysis]
12 Shen NT, Londono C, Gold S, Wu A, Mages KC, Brown RSJ. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes. World J Gastroenterol 2019; 25(13): 1628-1639 [PMID: 30983822 DOI: 10.3748/wjg.v25.i13.1628] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Huang Y, Niu M, Jing J, Zhang ZT, Zhao X, Chen SS, Li SS, Shi Z, Huang A, Zou ZS, Yu YC, Xiao XH, Liangpunsakul S, Wang JB. Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol-Associated Liver Cirrhosis. Hepatol Commun 2021;5:961-75. [PMID: 34141983 DOI: 10.1002/hep4.1699] [Reference Citation Analysis]
14 Kim HG, Huang M, Xin Y, Zhang Y, Zhang X, Wang G, Liu S, Wan J, Ahmadi AR, Sun Z, Liangpunsakul S, Xiong X, Dong XC. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice. J Hepatol 2019;71:960-9. [PMID: 31295533 DOI: 10.1016/j.jhep.2019.06.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
15 Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O'Connor PG, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA. Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial. J Subst Abuse Treat 2019;106:97-106. [PMID: 31540617 DOI: 10.1016/j.jsat.2019.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Xie YD, Zhao CQ, Wang JP, Cheng CS, Zhou JY, Zhang Y, Xia H, Wei L. Alcohol consumption analysis among patients with liver disease in China. Chin Med J (Engl) 2019;132:420-30. [PMID: 30707167 DOI: 10.1097/CM9.0000000000000067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Xiao J, Wang F, Wong NK, Lv Y, Liu Y, Zhong J, Chen S, Li W, Koike K, Liu X, Wang H. Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise. Gene Expr 2020;20:105-18. [PMID: 32690129 DOI: 10.3727/105221620X15952664091823] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kim HI, Park SY, Shin HP. Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study. Sci Rep 2021;11:6648. [PMID: 33758281 DOI: 10.1038/s41598-021-86197-z] [Reference Citation Analysis]
19 Zhang T, Li J, Liu CP, Guo M, Gao CL, Zhou LP, Long Y, Xu Y. Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis. Ann Transl Med 2021;9:873. [PMID: 34164507 DOI: 10.21037/atm-21-2158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Singal AK, Louvet A, Shah VH, Kamath PS. Grand Rounds: Alcoholic Hepatitis. J Hepatol. 2018;69:534-543. [PMID: 29753761 DOI: 10.1016/j.jhep.2018.05.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
21 Barbería-latasa M, Gea A, Martínez-gonzález MA. Alcohol, Drinking Pattern, and Chronic Disease. Nutrients 2022;14:1954. [DOI: 10.3390/nu14091954] [Reference Citation Analysis]
22 Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy. Nutrients 2020;12:E572. [PMID: 32098364 DOI: 10.3390/nu12020572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
23 Chiu WC, Shan JC, Yang YH, Chen VC, Chen PC. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder. Drug Alcohol Depend 2021;228:109096. [PMID: 34600254 DOI: 10.1016/j.drugalcdep.2021.109096] [Reference Citation Analysis]
24 Aulinas A, Guarda FJ, Yu EW, Haines MS, Asanza E, Silva L, Tritos NA, Verbalis J, Miller KK, Lawson EA. Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men. Neuroendocrinology 2021;111:87-98. [PMID: 32074621 DOI: 10.1159/000506638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Im GY, Neuberger J. Debate on Selection Criteria for Liver Transplantation for Alcoholic Hepatitis: Tighten or Loosen? Liver Transpl 2020;26:916-21. [DOI: 10.1002/lt.25783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Strainiene S, Peciulyte M, Strainys T, Stundiene I, Savlan I, Liakina V, Valantinas J. Management of Flood syndrome: What can we do better? World J Gastroenterol 2021; 27(32): 5297-5305 [PMID: 34539133 DOI: 10.3748/wjg.v27.i32.5297] [Reference Citation Analysis]
27 Kubiliun MJ, Rich NE, Singal A, Mufti AR. Pro: Liver Transplantation Should Be Considered in Select Patients With Acute Alcoholic Hepatitis. Clin Liver Dis (Hoboken) 2019;13:140-3. [PMID: 31236262 DOI: 10.1002/cld.780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jophlin L, Singal AK. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.009] [Reference Citation Analysis]
29 Lang Y, Zhang X, Li X, Xu Y. The mitophagosome, a novel ultrastructure of mitophagy in the alcoholic steatohepatitis mouse model: a transmission electron microscope study. Ultrastruct Pathol 2022;:1-8. [PMID: 35348040 DOI: 10.1080/01913123.2022.2059041] [Reference Citation Analysis]
30 Hilscher MB, Kamath PS. The Liver in Circulatory Disturbances. Clinics in Liver Disease 2019;23:209-20. [DOI: 10.1016/j.cld.2018.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
31 Fan H, Tu T, Zhang X, Yang Q, Liu G, Zhang T, Bao Y, Lu Y, Dong Z, Dong J, Zhao P. Sinomenine attenuates alcohol-induced acute liver injury via inhibiting oxidative stress, inflammation and apoptosis in mice. Food Chem Toxicol 2021;159:112759. [PMID: 34883223 DOI: 10.1016/j.fct.2021.112759] [Reference Citation Analysis]
32 Chung HG, Sinn DH, Kang W, Choi G, Kim JM, Joh J. Incidence of and Risk Factors for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease: Comparison Between Deceased Donor and Living Donor Liver Transplantation. J Gastrointest Surg 2021;25:672-80. [DOI: 10.1007/s11605-020-04540-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
34 Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
35 Sutoh Y, Hachiya T, Suzuki Y, Komaki S, Ohmomo H, Kakisaka K, Wang T, Takikawa Y, Shimizu A. ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis. Sci Rep 2020;10:16227. [PMID: 33004991 DOI: 10.1038/s41598-020-73263-1] [Reference Citation Analysis]
36 Testino G, Vignoli T, Patussi V, Scafato E, Caputo F; SIA board (Appendix A) and the external expert supervisors (Appendix B). Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA). Dig Liver Dis 2020;52:21-32. [PMID: 31757596 DOI: 10.1016/j.dld.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
37 Zhou Y, Vatsalya V, Gobejishvili L, Lamont RJ, McClain CJ, Feng W. Porphyromonas gingivalis as a Possible Risk Factor in the Development/Severity of Acute Alcoholic Hepatitis. Hepatol Commun 2019;3:293-304. [PMID: 30766965 DOI: 10.1002/hep4.1296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Szabo G, Kamath PS, Shah VH, Thursz M, Mathurin P; EASL-AASLD Joint Meeting. Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study. Hepatology. 2019;69:2271-2283. [PMID: 30645002 DOI: 10.1002/hep.30369] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
39 Su Y, Liu Z, Yang L, Li Y, Jiang S, Yao H, Du G. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China. Clin Res Hepatol Gastroenterol 2020;44:894-904. [PMID: 32505733 DOI: 10.1016/j.clinre.2020.02.005] [Reference Citation Analysis]
40 Altamirano J, Qi Q, Choudhry S, Abdallah M, Singal AK, Humar A, Bataller R, Borhani AA, Duarte-Rojo A. Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease. Transl Gastroenterol Hepatol. 2020;5:31. [PMID: 32258535 DOI: 10.21037/tgh.2019.11.14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
41 Fairfield B, Schnabl B. Gut dysbiosis as a driver in alcohol-induced liver injury. JHEP Rep 2021;3:100220. [PMID: 33598648 DOI: 10.1016/j.jhepr.2020.100220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Nunes Dos Santos K, Florentino RM, França A, Lima Filho ACM, Santos MLD, Missiaggia D, Fonseca MC, Brasil Costa I, Vidigal PVT, Nathanson MH, Lemos FO, Leite MF. Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse. Int J Mol Sci 2019;20:E3589. [PMID: 31340446 DOI: 10.3390/ijms20143589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Marrero I, Maricic I, Morgan TR, Stolz AA, Schnabl B, Liu ZX, Tsukamoto H, Kumar V. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease. Alcohol Clin Exp Res. 2020;44:1061-1074. [PMID: 32154597 DOI: 10.1111/acer.14323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Hu PF, Xie WF. Corticosteroid therapy in drug-induced liver injury: Pros and cons. J Dig Dis. 2019;20:122-126. [PMID: 30582289 DOI: 10.1111/1751-2980.12697] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
45 Ayyala-Somayajula D, Han H, Terrault NA. Selective use of liver transplantation for severe alcohol-associated hepatitis. Expert Rev Gastroenterol Hepatol 2020;14:175-84. [PMID: 32077333 DOI: 10.1080/17474124.2020.1733414] [Reference Citation Analysis]
46 Kim JH, Lee M, Park SW, Kang M, Kim M, Lee SH, Kim TS, Park JM, Choi DH. Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis. Medicine (Baltimore). 2018;97:e13438. [PMID: 30508959 DOI: 10.1097/md.0000000000013438] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Vyhmeister R, Enestvedt CK. The Changing Liver Transplant Recipient: From Hepatitis C to Nonalcoholic Steatohepatitis and Alcohol. Clin Liver Dis 2021;25:137-55. [PMID: 33978575 DOI: 10.1016/j.cld.2020.08.012] [Reference Citation Analysis]
48 Zhou J, Chen S, Zhang L, Zhai Y. Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report. Daru 2021. [PMID: 34817844 DOI: 10.1007/s40199-021-00420-w] [Reference Citation Analysis]
49 Siddique SM, May FP. Race-Based Clinical Recommendations in Gastroenterology. Gastroenterology 2021:S0016-5085(21)04050-6. [PMID: 34890599 DOI: 10.1053/j.gastro.2021.12.234] [Reference Citation Analysis]
50 Caputo F, Testino G. Orthotopic liver transplantation for patients with end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis. Minerva Surg 2021;76:444-9. [PMID: 33433074 DOI: 10.23736/S2724-5691.20.08685-X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Sundaram V, Morgan TR. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis? Clinics in Liver Disease 2019;23:157-65. [DOI: 10.1016/j.cld.2018.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Palmer G, Singal AK. Refining criteria for liver biopsy in severe alcoholic hepatitis: Moving the field forward. United European Gastroenterol J 2020;8:993-4. [PMID: 32869737 DOI: 10.1177/2050640620957140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 2019;20:E2712. [PMID: 31159489 DOI: 10.3390/ijms20112712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
54 Michalak A, Lach T, Cichoż-Lach H. Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease. J Clin Med 2021;10:3011. [PMID: 34300175 DOI: 10.3390/jcm10143011] [Reference Citation Analysis]
55 Cabezas J. Management of Alcohol-Related Liver Disease and Its Complications. Clin Drug Investig 2022. [PMID: 35467296 DOI: 10.1007/s40261-022-01143-9] [Reference Citation Analysis]
56 Li LX, Guo FF, Liu H, Zeng T. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets. Cell Mol Life Sci 2022;79:201. [PMID: 35325321 DOI: 10.1007/s00018-022-04239-9] [Reference Citation Analysis]
57 Lee BP, Terrault NA. Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise. Transl Gastroenterol Hepatol 2019;4:19. [PMID: 30976722 DOI: 10.21037/tgh.2019.03.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
58 Abdallah MA, Singal AK. Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target. Signal Transduct Target Ther 2020;5:26. [PMID: 32296016 DOI: 10.1038/s41392-020-0128-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
59 Chu J, Yan R, Wang S, Li G, Kang X, Hu Y, Lin M, Shan W, Zhao Y, Wang Z, Sun R, Yao J, Zhang N. Sinapic Acid Reduces Oxidative Stress and Pyroptosis via Inhibition of BRD4 in Alcoholic Liver Disease. Front Pharmacol 2021;12:668708. [PMID: 34149421 DOI: 10.3389/fphar.2021.668708] [Reference Citation Analysis]
60 Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016. JAMA 2019;321:1723-5. [PMID: 31063562 DOI: 10.1001/jama.2019.2276] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 13.7] [Reference Citation Analysis]
61 Meroni M, Longo M, Rametta R, Dongiovanni P. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. Int J Mol Sci. 2018;19:3857. [PMID: 30513996 DOI: 10.3390/ijms19123857] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
62 Chrostek L, Przekop D, Gruszewska E, Gudowska-Sawczuk M, Cylwik B. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics. Biomed Res Int 2019;2019:3646975. [PMID: 31192254 DOI: 10.1155/2019/3646975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, Yu H, Yu Y, Wu C, Ou B, Peng Z. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med 2022. [PMID: 35118819 DOI: 10.1002/cam4.4551] [Reference Citation Analysis]
64 Aljohani W, Chan BPH, Yaghoobi M. Role of N-Acetylcysteine in the Treatment of Acute Nonacetaminophen, Nonalcoholic and Nonviral Hepatitis: A Meta-analysis. J Can Assoc Gastroenterol 2021;4:125-30. [PMID: 34056530 DOI: 10.1093/jcag/gwaa017] [Reference Citation Analysis]
65 Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol 2019;16:235-46. [DOI: 10.1038/s41575-018-0099-1] [Cited by in Crossref: 122] [Cited by in F6Publishing: 120] [Article Influence: 40.7] [Reference Citation Analysis]
66 Shipley LC, Singal AK. Liver transplantation for alcoholic hepatitis. Transl Gastroenterol Hepatol 2020;5:26. [PMID: 32258530 DOI: 10.21037/tgh.2019.11.17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Ventura-Cots M, Watts AE, Cruz-Lemini M, Shah ND, Ndugga N, McCann P, Barritt AS 4th, Jain A, Ravi S, Fernandez-Carrillo C, Abraldes JG, Altamirano J, Bataller R. Colder Weather and Fewer Sunlight Hours Increase Alcohol Consumption and Alcoholic Cirrhosis Worldwide. Hepatology 2019;69:1916-30. [PMID: 30324707 DOI: 10.1002/hep.30315] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
68 Mao J, Zhan H, Meng F, Wang G, Huang D, Liao Z, Chen M. Costunolide protects against alcohol-induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitro. Phytother Res 2022. [PMID: 35084790 DOI: 10.1002/ptr.7383] [Reference Citation Analysis]
69 Marot A, Singal AK, Moreno C, Deltenre P. Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials. JHEP Rep 2020;2:100139. [PMID: 32775975 DOI: 10.1016/j.jhepr.2020.100139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
70 Hyun J, Han J, Lee C, Yoon M, Jung Y. Pathophysiological Aspects of Alcohol Metabolism in the Liver. Int J Mol Sci 2021;22:5717. [PMID: 34071962 DOI: 10.3390/ijms22115717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Gelu-Simeon M, Mathurin P. Liver Transplantation for Severe Alcoholic Hepatitis: Where Are We Now? Liver Transpl 2018;24:1327-8. [PMID: 30218596 DOI: 10.1002/lt.25337] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
73 Dang K, Hirode G, Singal AK, Sundaram V, Wong RJ. Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases. Am J Gastroenterol 2020;115:96-104. [DOI: 10.14309/ajg.0000000000000380] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
74 Song X, Cui W, Meng F, Xia Q, Li X, Hou M, Jia L, Zhang J. Glucopyranose from Pleurotus geesteranus prevent alcoholic liver diseases by regulating Nrf2/HO-1-TLR4/NF-κB signalling pathways and gut microbiota. Food Funct 2022. [PMID: 35048917 DOI: 10.1039/d1fo03486c] [Reference Citation Analysis]
75 Moon AM, Yang JY, Barritt AS, Bataller R, Peery AF. Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century. Am J Gastroenterol 2020;115:79-87. [DOI: 10.14309/ajg.0000000000000442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
76 Lee BP, Vittinghoff E, Pletcher MJ, Dodge JL, Terrault NA. Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease. Hepatology 2020;72:130-9. [PMID: 31705545 DOI: 10.1002/hep.31027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
77 Srinivasan MP, Bhopale KK, Amer SM, Wan J, Kaphalia L, Ansari GS, Kaphalia BS. Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice. Biomolecules 2019;9:E560. [PMID: 31581705 DOI: 10.3390/biom9100560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
78 Raikhelson KL, Kondrashina EA, Pazenko EV. [Mixed steatohepatitis: more questions than answers (Part 1)]. Ter Arkh 2020;92:91-6. [PMID: 33720580 DOI: 10.26442/00403660.2020.12.200470] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Cui B, Lin L, Wang B, Liu W, Sun C. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer? Pharmacol Res 2021;175:106022. [PMID: 34883213 DOI: 10.1016/j.phrs.2021.106022] [Reference Citation Analysis]
80 Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep 2020;2:100101. [PMID: 32514497 DOI: 10.1016/j.jhepr.2020.100101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
81 Forrest EH, Atkinson SR, Richardson P, Masson S, Ryder S, Thursz MR, Allison M. ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established. Am J Gastroenterol 2019;114:175-6. [PMID: 29887598 DOI: 10.1038/s41395-018-0076-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Liu C, Wang YL, Yang YY, Zhang NP, Niu C, Shen XZ, Wu J. Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases. FASEB J 2021;35:e21871. [PMID: 34473374 DOI: 10.1096/fj.202100939R] [Reference Citation Analysis]
83 Yang Y, Wang X, Cao J, Li J. Clinical characteristics and survival analysis of liver transplantation in patients with alcoholic liver disease: A single-center retrospective study. Transplant Immunology 2022. [DOI: 10.1016/j.trim.2022.101569] [Reference Citation Analysis]
84 Ting PS, Gurakar A, Wheatley J, Chander G, Cameron AM, Chen PH. Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis. Clin Liver Dis 2021;25:645-71. [PMID: 34229846 DOI: 10.1016/j.cld.2021.03.008] [Reference Citation Analysis]
85 Gopal T, Ai W, Casey CA, Donohue TM Jr, Saraswathi V. A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease. Alcohol Clin Exp Res 2021;45:1927-39. [PMID: 34558087 DOI: 10.1111/acer.14698] [Reference Citation Analysis]
86 Veryan J, Forrest EH. Recent advances in alcoholic hepatitis. Frontline Gastroenterol 2020;11:133-9. [PMID: 32133112 DOI: 10.1136/flgastro-2018-101104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Bhandari R, Khaliq K, Ravat V, Kaur P, Patel RS. Chronic Alcoholic Liver Disease and Mortality Risk in Spontaneous Bacterial Peritonitis: Analysis of 6,530 Hospitalizations. Cureus 2020;12:e8189. [PMID: 32566430 DOI: 10.7759/cureus.8189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Antonelli M, Sestito L, Tarli C, Addolorato G. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective? Eur J Intern Med 2022:S0953-6205(22)00194-7. [PMID: 35597734 DOI: 10.1016/j.ejim.2022.05.016] [Reference Citation Analysis]
89 Van J, Aloman C, Reau N. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol 2021;116:2089-97. [PMID: 34193797 DOI: 10.14309/ajg.0000000000001349] [Reference Citation Analysis]
90 Solga SF, Serper M, Young RA, Forde KA. Transplantation for Alcoholic Hepatitis: Are We Achieving Justice and Utility? Hepatology 2019;69:1798-802. [PMID: 30561847 DOI: 10.1002/hep.30471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
91 Yan J, Nie Y, Luo M, Chen Z, He B. Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Front Pharmacol 2021;12:694475. [PMID: 34290612 DOI: 10.3389/fphar.2021.694475] [Reference Citation Analysis]
92 Deltenre P, Marot A, Moreno C. Outcomes After Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis: Additional Evidence From a Meta-analysis. Gastroenterology 2019;156:285-6. [PMID: 30315775 DOI: 10.1053/j.gastro.2018.09.057] [Reference Citation Analysis]
93 Liu SX, Liu H, Wang S, Zhang CL, Guo FF, Zeng T. Diallyl disulfide ameliorates ethanol-induced liver steatosis and inflammation by maintaining the fatty acid catabolism and regulating the gut-liver axis. Food Chem Toxicol 2022;:113108. [PMID: 35526736 DOI: 10.1016/j.fct.2022.113108] [Reference Citation Analysis]
94 Wang XP, Im SJ, Balchak DM, Montalbetti N, Carattino MD, Ray EC, Kashlan OB. Murine epithelial sodium (Na+) channel regulation by biliary factors. J Biol Chem 2019;294:10182-93. [PMID: 31092599 DOI: 10.1074/jbc.RA119.007394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
95 Fu K, Zhou H, Wang C, Gong L, Ma C, Zhang Y, Li Y. A review: Pharmacology and pharmacokinetics of Schisandrin A. Phytotherapy Research. [DOI: 10.1002/ptr.7456] [Reference Citation Analysis]
96 Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis 2019;23:39-50. [PMID: 30454831 DOI: 10.1016/j.cld.2018.09.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
97 Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology 2020;72:441-53. [PMID: 31774566 DOI: 10.1002/hep.31046] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
98 Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol 2019;70:305-13. [PMID: 30658731 DOI: 10.1016/j.jhep.2018.10.026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
99 Hu S, Yao Y, Wei ZY, Wang SX, Wu YC, Hu Y, Yang CC, Min JL, Li LY, Zhou H, Yang JF, Li J, Xu T. Deletion of p38γ attenuates ethanol consumption- and acetaminophen-induced liver injury in mice through promoting Dlg1. Acta Pharmacol Sin 2021. [PMID: 34789918 DOI: 10.1038/s41401-021-00795-1] [Reference Citation Analysis]
100 Xu JJ, Zhu L, Li HD, Du XS, Li JJ, Yin NN, Meng XM, Huang C, Li J. DNMT3a-mediated methylation of PSTPIP2 enhances inflammation in alcohol-induced liver injury via regulating STAT1 and NF-κB pathway. Pharmacol Res 2022;:106125. [PMID: 35149186 DOI: 10.1016/j.phrs.2022.106125] [Reference Citation Analysis]
101 Sun J, Li B, Sun A, Zhao K, Ma Y, Zhao J, Pan H, Song Q, Wang Y, Yu C, Wang C, Zhang H, Zhang W, Kong C. Comprehensive analysis of aberrantly expressed profiles of messenger RNA in alcoholic liver disease. J Cell Biochem 2019;120:4248-54. [PMID: 30294942 DOI: 10.1002/jcb.27710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Lee RM, Gamboa AC, Turgeon MK, Yopp A, Ryon EL, Kronenfeld JP, Goel N, Wang A, Lee AY, Luu S, Hsu C, Silberfein E, Maithel SK, Russell MC. The Evolving Landscape of Hepatocellular Carcinoma : A US Safety Net Collaborative Analysis of Etiology of Cirrhosis. Am Surg 2020;86:865-72. [PMID: 32721171 DOI: 10.1177/0003134820939934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 McElroy LM, Likhitsup A, Scott Winder G, Saeed N, Hassan A, Sonnenday CJ, Fontana RJ, Mellinger J. Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation. Transplantation 2020;104:293-8. [PMID: 31283683 DOI: 10.1097/TP.0000000000002843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
104 Sun Z, Chang B, Huang A, Hao S, Gao M, Sun Y, Shi M, Jin L, Zhang W, Zhao J, Teng G, Han L, Tian H, Liang Q, Zhang JY, Zou Z. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease. J Cell Mol Med 2019;23:887-97. [PMID: 30478965 DOI: 10.1111/jcmm.13990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
105 Donde H, Ghare S, Joshi-Barve S, Zhang J, Vadhanam MV, Gobejishvili L, Lorkiewicz P, Srivastava S, McClain CJ, Barve S. Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury. Cell Mol Gastroenterol Hepatol. 2020;9:569-585. [PMID: 31654770 DOI: 10.1016/j.jcmgh.2019.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
106 Hilscher MB, Kamath PS, Eaton JE. Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists. Mayo Clin Proc 2020;95:2263-79. [PMID: 33012354 DOI: 10.1016/j.mayocp.2020.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Nawroth JC, Petropolis DB, Manatakis DV, Maulana TI, Burchett G, Schlünder K, Witt A, Shukla A, Kodella K, Ronxhi J, Kulkarni G, Hamilton G, Seki E, Lu S, Karalis KC. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Rep 2021;36:109393. [PMID: 34289365 DOI: 10.1016/j.celrep.2021.109393] [Reference Citation Analysis]
108 Kim DH, Sim Y, Hwang JH, Kwun IS, Lim JH, Kim J, Kim JI, Baek MC, Akbar M, Seo W, Kim DK, Song BJ, Cho YE. Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative Stress. Antioxidants (Basel) 2021;10:1386. [PMID: 34573017 DOI: 10.3390/antiox10091386] [Reference Citation Analysis]
109 Gala KS, Vatsalya V. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope. Cells 2020;9:E524. [PMID: 32106390 DOI: 10.3390/cells9030524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Yang DH, Wang WP, Zhang Q, Pan HY, Huang YC, Zhang JJ. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World J Gastroenterol 2021; 27(17): 2025-2038 [PMID: 34007137 DOI: 10.3748/wjg.v27.i17.2025] [Reference Citation Analysis]
111 Addolorato G, Vassallo GA, Mirijello A, Gasbarrini A. Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows. Neurotherapeutics 2020;17:127-41. [PMID: 31713188 DOI: 10.1007/s13311-019-00802-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
112 Varghese J, Varghese James J, Karthikeyan M, Rasalkar K, Raghavan R, Sukumaran A, Premkumar PS, Eapen CE, Jacob M. Iron homeostasis is dysregulated, but the iron-hepcidin axis is functional, in chronic liver disease. J Trace Elem Med Biol 2020;58:126442. [PMID: 31835128 DOI: 10.1016/j.jtemb.2019.126442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
113 Zeng D, Huang Q, Yu Z, Wu H. Association between aldehyde dehydrogenase 2 gene rs671 G>A polymorphism and alcoholic liver cirrhosis in southern Chinese Hakka population. J Clin Lab Anal 2021;35:e23855. [PMID: 34033144 DOI: 10.1002/jcla.23855] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 He L, Sehrawat TS, Verma VK, Navarro-Corcuera A, Sidhu G, Mauer A, Luo X, Katsumi T, Chen J, Shah S, Arab JP, Cao S, Kashkar H, Gores GJ, Malhi H, Shah VH. XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC. Front Physiol 2021;12:664222. [PMID: 34025452 DOI: 10.3389/fphys.2021.664222] [Reference Citation Analysis]
115 Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C. Glucocorticosteroids for people with alcoholic hepatitis. Cochrane Database Syst Rev 2019;4:CD001511. [PMID: 30964545 DOI: 10.1002/14651858.CD001511.pub4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
116 An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D, Nieß H, Andrassy J, Guba M, Bazhin AV, Werner J, Kühn F. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. J Gastrointest Surg 2021. [PMID: 34734369 DOI: 10.1007/s11605-021-05188-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Roth EM, Lee EJ, Cameron AM, Shen NT, Brown RS Jr, DiMartini AF, Shenoy A. A Young Patient with Brief Alcohol Use and Rapidly Progressive Alcohol-Related Hepatitis: Considerations in Transplant Eligibility. Harv Rev Psychiatry 2020;28:133-42. [PMID: 32134837 DOI: 10.1097/HRP.0000000000000249] [Reference Citation Analysis]
118 Chand PK, Panda U, Mahadevan J, Murthy P. Management of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.003] [Reference Citation Analysis]
119 Ma M, Falloon K, Chen PH, Saberi B, Pustavoitau A, Ozdogan E, Li Z, Philosophe B, Cameron AM, Gurakar A. The Role of Liver Transplantation in Alcoholic Hepatitis. J Intensive Care Med 2019;34:277-91. [PMID: 29879862 DOI: 10.1177/0885066618780339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Zhou J, Zhang N, Zhao L, Mohamed Soliman M, Wu W, Li J, Zhou F, Zhang L, Aadil RM. Protective Effects of Honey-Processed Astragalus on Liver Injury and Gut Microbiota in Mice Induced by Chronic Alcohol Intake. Journal of Food Quality 2022;2022:1-12. [DOI: 10.1155/2022/5333691] [Reference Citation Analysis]
121 Li Y, Liu H, Chen K, Wu X, Wu J, Yang Z, Yao L, Wen G, Zhang C, Chen X, Chen X, Tang D, Wang X, Liu J. Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy. Front Med (Lausanne) 2021;8:706407. [PMID: 34527681 DOI: 10.3389/fmed.2021.706407] [Reference Citation Analysis]
122 Chang C, Wang TJ, Chen MJ, Liang SY, Wu SF, Bai MJ. Factors influencing readiness to change in patients with alcoholic liver disease: A cross-sectional study. J Psychiatr Ment Health Nurs 2021;28:344-55. [PMID: 32667735 DOI: 10.1111/jpm.12677] [Reference Citation Analysis]
123 Jothimani D, Danielraj S, Narasimhan G, Kaliamoorthy I, Rajakumar A, Palaniappan K, Palanichamy S, Rammohan A, Ramachandran H, Rajalingam R, Rela M. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.09.017] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Prasun P, Ginevic I, Oishi K. Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease. Transl Gastroenterol Hepatol 2021;6:4. [PMID: 33437892 DOI: 10.21037/tgh-20-125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
125 Thomes PG, Rasineni K, Saraswathi V, Kharbanda KK, Clemens DL, Sweeney SA, Kubik JL, Donohue TM Jr, Casey CA. Natural Recovery by the Liver and Other Organs after Chronic Alcohol Use. Alcohol Res 2021;41:05. [PMID: 33868869 DOI: 10.35946/arcr.v41.1.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Habash NW, Sehrawat TS, Shah VH, Cao S. Epigenetics of Alcohol-Related Liver Diseases. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100466] [Reference Citation Analysis]
127 Wightman A, Goldberg A, Diekema D. Considering a COVID-19 vaccine mandate for pediatric kidney transplant candidates. Pediatr Nephrol 2022. [PMID: 35333972 DOI: 10.1007/s00467-022-05511-7] [Reference Citation Analysis]
128 Chen VC, Lee MJ, Yang YH, Lu ML, Chiu WC, Dewey ME. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder. Drug Alcohol Depend 2021;219:108495. [PMID: 33429293 DOI: 10.1016/j.drugalcdep.2020.108495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Ness C, Hardie K, Holbeck M, Saucedo-crespo H, Auvenshine C, Steers J, Sakpal SV. Integration of addiction treatment and behavioral therapies in comprehensive liver transplantation care to augment adherence and reduce alcohol relapse. Journal of Liver Transplantation 2022;5:100061. [DOI: 10.1016/j.liver.2021.100061] [Reference Citation Analysis]
130 Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34725498 DOI: 10.1038/s41575-021-00527-0] [Reference Citation Analysis]
131 Ezhilarasan D. Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2020;19:429-34. [DOI: 10.1016/j.hbpd.2020.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Thursz M, Kamath PS, Mathurin P, Szabo G, Shah VH. Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study. Journal of Hepatology 2019;70:521-30. [DOI: 10.1016/j.jhep.2018.10.041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
133 Sun FR, Wang BY. Alcohol and Metabolic-associated Fatty Liver Disease. J Clin Transl Hepatol 2021;9:719-30. [PMID: 34722187 DOI: 10.14218/JCTH.2021.00173] [Reference Citation Analysis]
134 Xu H, Wang H. Immune cells in alcohol-related liver disease. Liver Research 2022. [DOI: 10.1016/j.livres.2022.01.001] [Reference Citation Analysis]
135 Lu J, Zhang Y, Wang YZ, Li YY, Wang R, Zhong YJ, Chen L, Song MW, Shi L, Li L, Li YW. Caffeic acid dimethyl ether alleviates alcohol-induced hepatic steatosis via microRNA-378b-mediated CaMKK2-AMPK pathway. Bioengineered 2022;13:11122-36. [PMID: 35481488 DOI: 10.1080/21655979.2022.2060586] [Reference Citation Analysis]
136 Majeed MB, Agrawal R, Attar BM, Abu Omar Y, Gandhi SR. Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review. Cureus 2019;11:e5082. [PMID: 31516791 DOI: 10.7759/cureus.5082] [Reference Citation Analysis]
137 Marroni CA, Fleck Jr AM, Fernandes SA, Galant LH, Mucenic M, de Mattos Meine MH, Mariante-Neto G, Brandão ABM. Liver transplantation and alcoholic liver disease: History, controversies, and considerations. World J Gastroenterol 2018; 24(26): 2785-2805 [PMID: 30018475 DOI: 10.3748/wjg.v24.i26.2785] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
138 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.02.001] [Reference Citation Analysis]
139 Wang L, Kong L, Xu S, Wang X, Huang K, Wang S, Wu J, Wang C, Sun H, Liu K, Meng Q. Isoliquiritigenin-mediated miR-23a-3p inhibition activates PGC-1α to alleviate alcoholic liver injury. Phytomedicine 2021;:153845. [PMID: 34785106 DOI: 10.1016/j.phymed.2021.153845] [Reference Citation Analysis]
140 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
141 Chung MW, Kim UJ, Jun CH, Cho SB, Park SY, Park CH, Kim HS, Choi SK, Rew JS. Pneumocystis pneumonia after use of corticosteroids in a man with severe alcoholic hepatitis: A case report. Medicine (Baltimore) 2020;99:e18696. [PMID: 31914071 DOI: 10.1097/MD.0000000000018696] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Park S, Kang S. High carbohydrate and noodle/meat-rich dietary patterns interact with the minor haplotype in the 22q13 loci to increase its association with non-alcoholic fatty liver disease risk in Koreans. Nutr Res 2020;82:88-98. [PMID: 32977255 DOI: 10.1016/j.nutres.2020.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Ray G, Manjubhargav P. Clinical Presentation and Mortality Determinants of Alcohol-Related Liver Disease: A Single-Center Experience of the Rising Menace from Eastern India. Inflamm Intest Dis 2019;4:104-14. [PMID: 31559262 DOI: 10.1159/000501274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Mellinger JL, Stine JG. Early Liver Transplantation for Severe Alcoholic Hepatitis. Dig Dis Sci 2020;65:1608-14. [PMID: 32107678 DOI: 10.1007/s10620-020-06159-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
145 Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F, Restrepo JC, Torre A, Urzua A, Simonetto DA, Abraldes JG, Méndez-Sánchez N, Contreras F, Lucey MR, Shah VH, Cortez-Pinto H, Bataller R. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 2019;18:518-35. [PMID: 31053546 DOI: 10.1016/j.aohep.2019.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
146 Thomes PG, Rasineni K, Yang L, Donohue TM Jr, Kubik JL, McNiven MA, Casey CA. Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism. Am J Physiol Gastrointest Liver Physiol. 2019;316:G509-G518. [PMID: 30714813 DOI: 10.1152/ajpgi.00376.2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
147 Stickel F, Lutz P, Buch S, Nischalke HD, Silva I, Rausch V, Fischer J, Weiss KH, Gotthardt D, Rosendahl J, Marot A, Elamly M, Krawczyk M, Casper M, Lammert F, Buckley TWM, McQuillin A, Spengler U, Eyer F, Vogel A, Marhenke S, von Felden J, Wege H, Sharma R, Atkinson S, Franke A, Nehring S, Moser V, Schafmayer C, Spahr L, Lackner C, Stauber RE, Canbay A, Link A, Valenti L, Grove JI, Aithal GP, Marquardt JU, Fateen W, Zopf S, Dufour JF, Trebicka J, Datz C, Deltenre P, Mueller S, Berg T, Hampe J, Morgan MY. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. Hepatology 2020;72:88-102. [PMID: 31630428 DOI: 10.1002/hep.30996] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 12.5] [Reference Citation Analysis]
148 Wang YZ, Lu J, Li YY, Zhong YJ, Yang CF, Zhang Y, Huang LH, Huang SM, Li QR, Wu D, Song MW, Shi L, Li L, Li YW. microRNA-378b regulates ethanol-induced hepatic steatosis by targeting CaMKK2 to mediate lipid metabolism. Bioengineered 2021;12:12659-76. [PMID: 34898362 DOI: 10.1080/21655979.2021.2003677] [Reference Citation Analysis]
149 Clemente-Sánchez A, Oliveira-Mello A, Bataller R. Moderate Alcoholic Hepatitis. Clin Liver Dis 2021;25:537-55. [PMID: 34229838 DOI: 10.1016/j.cld.2021.03.001] [Reference Citation Analysis]
150 Dasarathy S, Mitchell MC, Barton B, McClain CJ, Szabo G, Nagy LE, Radaeva S, McCullough AJ. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. Contemp Clin Trials 2020;96:106094. [PMID: 32739495 DOI: 10.1016/j.cct.2020.106094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
151 Wen B, Zhang C, Zhou J, Zhang Z, Che Q, Cao H, Bai Y, Guo J, Su Z. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther 2021;222:107752. [PMID: 33253739 DOI: 10.1016/j.pharmthera.2020.107752] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Abulaimoun S, Abushalha K, Reddymasu S, Teruya B, Natarajan N. Hemophagocytic Lymphohistiocytosis Masquerading as Alcoholic Hepatitis. ACG Case Rep J 2020;7:e00495. [PMID: 33324714 DOI: 10.14309/crj.0000000000000495] [Reference Citation Analysis]
153 Melis M, Tang XH, Attarwala N, Chen Q, Prishker C, Qin L, Gross SS, Gudas LJ, Trasino SE. A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes. Biofactors 2021. [PMID: 34687254 DOI: 10.1002/biof.1794] [Reference Citation Analysis]
154 Suzuki Y, Kakisaka K, Suzuki A, Takahara T, Sasaki T, Sato T, Yonezawa T, Nitta H, Takikawa Y. A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients. Hepatol Res 2019;49:758-64. [PMID: 30901152 DOI: 10.1111/hepr.13334] [Reference Citation Analysis]
155 Greenberg R, Goldberg A, Anthony S, Buchman DZ, Delaney S, Gruben V, Holdsworth S, Le Foll B, Leung M, Lien D, Lynch MJ, Selzner N, Chandler JA, Fortin MC. Canadian Society of Transplantation White Paper: Ethical and Legal Considerations for Alcohol and Cannabis Use in Solid Organ Listing and Allocation. Transplantation 2021;105:1957-64. [PMID: 33587429 DOI: 10.1097/TP.0000000000003618] [Reference Citation Analysis]
156 Ladhani S, Hirode G, Singal AK, Wong RJ. Impact of Safety-Net Burden on In-Hospital Mortality and Hospitalization Costs Among Patients with Alcoholic Hepatitis and Alcoholic Cirrhosis. Alcohol and Alcoholism 2021;56:368-75. [DOI: 10.1093/alcalc/agaa081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31558-5. [PMID: 33279780 DOI: 10.1016/j.cgh.2020.11.024] [Reference Citation Analysis]
158 Elfeki MA, Singal AK. Early Liver Transplantation: An Evolving Therapeutic Option for Alcohol-Associated Liver Disease. Journal of Clinical and Experimental Hepatology 2022;12:3-5. [DOI: 10.1016/j.jceh.2021.10.144] [Reference Citation Analysis]
159 Wang H, Mehal W, Nagy LE, Rotman Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol 2021;18:73-91. [PMID: 33268887 DOI: 10.1038/s41423-020-00579-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
160 Song DS. [Medical Treatment of Alcoholic Liver Disease]. Korean J Gastroenterol 2020;76:65-70. [PMID: 32839368 DOI: 10.4166/kjg.2020.76.2.65] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Roth NC, Qin J. Histopathology of Alcohol-Related Liver Diseases. Clin Liver Dis 2019;23:11-23. [PMID: 30454825 DOI: 10.1016/j.cld.2018.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
162 Roeb E. Non-alcoholic fatty liver diseases: current challenges and future directions. Ann Transl Med 2021;9:726. [PMID: 33987424 DOI: 10.21037/atm-20-3760] [Reference Citation Analysis]
163 Cao H, Guo Y, Jin L. A Study on Gentiana dahurica Fisch Ethanol Extract Alleviating Alcoholic Liver Disease in Mice: A Metabolomic Analysis of the Liver. Evid Based Complement Alternat Med 2021;2021:5569538. [PMID: 34257684 DOI: 10.1155/2021/5569538] [Reference Citation Analysis]
164 Lang S, Fairfied B, Gao B, Duan Y, Zhang X, Fouts DE, Schnabl B. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients. Gut Microbes 2020;12:1785251. [PMID: 32684075 DOI: 10.1080/19490976.2020.1785251] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
165 Balakrishnan M, Pappas SC. Alcohol and the Law. Clinics in Liver Disease 2019;23:25-38. [DOI: 10.1016/j.cld.2018.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
166 Rahman MA, Patters BJ, Kodidela S, Kumar S. Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies. J Neuroimmune Pharmacol 2020;15:409-21. [PMID: 30955131 DOI: 10.1007/s11481-019-09848-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
167 Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 2021;6:291. [PMID: 34344870 DOI: 10.1038/s41392-021-00687-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
168 Saeki C, Saito M, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease. PLoS One 2021;16:e0249728. [PMID: 33798236 DOI: 10.1371/journal.pone.0249728] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl 2020;26:127-40. [PMID: 31743578 DOI: 10.1002/lt.25681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 28.0] [Reference Citation Analysis]
170 Wei Q, Guo JS. Developing natural marine products for treating liver diseases. World J Clin Cases 2022; 10(8): 2369-2381 [DOI: 10.12998/wjcc.v10.i8.2369] [Reference Citation Analysis]
171 Louvet A, Trabut JB, Moreno C, Moirand R, Aubin HJ, Ntandja Wandji LC, Nourredine M, Ningarhari M, Ganne-Carrié N, Pageaux GP, Bailly F, Boursier J, Daeppen JB, Luquiens A, Nguyen-Khac E, Anty R, Orban T, Donnadieu-Rigole H, Mallat A, Bureau C, Pariente EA, Paupard T, Benyamina A, Perney P, Mathurin P, Rolland B; for the Groupe collaboratif AFEF-SFA Maladie du foie liée à l'alcool. Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines. Liver Int 2022. [PMID: 35488390 DOI: 10.1111/liv.15221] [Reference Citation Analysis]
172 Arab JP, Arrese M, Singal AK. Diagnosis of Alcohol-Associated Hepatitis: When Is Liver Biopsy Required? Clin Liver Dis 2021;25:571-84. [PMID: 34229840 DOI: 10.1016/j.cld.2021.03.003] [Reference Citation Analysis]
173 Amjad W, Alukal J, Doycheva I, Zhang T, Maheshwari A, Yoo H, Thuluvath PJ. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis. Dig Dis Sci 2020;65:3726-33. [DOI: 10.1007/s10620-020-06142-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
174 Forrest EH, Storey N, Sinha R, Atkinson SR, Vergis N, Richardson P, Masson S, Ryder S, Thursz MR, Allison M, Fraser A, Austin A, Mccune A, Dhanda A, Katarey D, Potts J, Verma S, Parker R, Hayes PC; the STOPAH NLR Group. Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis. Aliment Pharmacol Ther 2019;50:442-53. [DOI: 10.1111/apt.15335] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
175 Ding JH, Jin Z, Yang XX, Lou J, Shan WX, Hu YX, Du Q, Liao QS, Xie R, Xu JY. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol 2020; 26(40): 6141-6162 [PMID: 33177790 DOI: 10.3748/wjg.v26.i40.6141] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
176 Zhang J, Lin Y, Zhang L. Trends in Alcoholic Fatty Liver Disease. JAMA 2019;322:979. [DOI: 10.1001/jama.2019.10347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
177 Ivanics T, Shwaartz C, Claasen MPAW, Patel MS, Yoon P, Raschzok N, Wallace D, Muaddi H, Murillo Perez CF, Hansen BE, Selzner N, Sapisochin G. Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study. Transpl Int 2021;34:1444-54. [PMID: 33977568 DOI: 10.1111/tri.13903] [Reference Citation Analysis]
178 Han MAT. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome. Life (Basel) 2020;10:E198. [PMID: 32933184 DOI: 10.3390/life10090198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
179 Kakati D, Kumar U, Russ K, Shoreibah M, Kuo YF, Jackson B, Singal AK. Cholecystectomy does not worsen progression or outcomes in non-alcoholic fatty liver disease. Transl Gastroenterol Hepatol 2020;5:3. [PMID: 32190771 DOI: 10.21037/tgh.2019.09.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Caputo F, Domenicali M, Bernardi M. Diagnosis and Treatment of Alcohol Use Disorder in Patients With End-Stage Alcoholic Liver Disease. Hepatology 2019;70:410-7. [PMID: 30471136 DOI: 10.1002/hep.30358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
181 Wang T, Wang Z, Yang Z, Cui X, Yan L, Xu Z, Liu X. Effect of the Fermentation Broth of the Mixture of Pueraria lobata, Lonicera japonica, and Crataegus pinnatifida by Lactobacillus rhamnosus 217-1 on Liver Health and Intestinal Flora in Mice With Alcoholic Liver Disease Induced by Liquor. Front Microbiol 2021;12:722171. [PMID: 34484163 DOI: 10.3389/fmicb.2021.722171] [Reference Citation Analysis]
182 Thanda Han MA, Pyrsopoulos N. Emerging Therapies for Alcoholic Hepatitis. Clin Liver Dis 2021;25:603-24. [PMID: 34229843 DOI: 10.1016/j.cld.2021.03.006] [Reference Citation Analysis]
183 Shirazi F, Singal AK, Wong RJ. Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States. J Clin Gastroenterol 2021;55:174-9. [PMID: 32520887 DOI: 10.1097/MCG.0000000000001378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Addolorato G, Abenavoli L, Dallio M, Federico A, Germani G, Gitto S, Leandro G, Loguercio C, Marra F, Stasi E. Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2020;52:374-91. [PMID: 32001151 DOI: 10.1016/j.dld.2019.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
185 Trebicka J, Louvet A, Arroyo V, Jalan R, Shah VH, Moreau R. Severe alcoholic hepatitis as precipitant for organ failure and ACLF. Z Gastroenterol 2022;60:67-76. [PMID: 35042255 DOI: 10.1055/a-1713-3796] [Reference Citation Analysis]
186 Fan X, McCullough RL, Huang E, Bellar A, Kim A, Poulsen KL, McClain CJ, Mitchell M, McCullough AJ, Radaeva S, Barton B, Szabo G, Dasarathy S, Rotroff DM, Nagy LE. Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated Hepatitis. Hepatology 2021;73:983-97. [PMID: 32557728 DOI: 10.1002/hep.31419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
187 Yin L, Zhang Y, Shi H, Feng Y, Zhang Z, Zhang L. Proteomic profiling of hepatic stellate cells in alcohol liver fibrosis reveals proteins involved in collagen production. Alcohol 2020;86:81-91. [PMID: 32171770 DOI: 10.1016/j.alcohol.2020.02.167] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Bloom PP, Mojtahed A, Bethea ED, Knooihuizen SA, Choi J, Dienstag JL, Chung RT, Hur C. Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes. Dig Dis Sci 2020;65:312-21. [PMID: 31363954 DOI: 10.1007/s10620-019-05721-4] [Reference Citation Analysis]
189 Dimartini AF, Leggio L, Singal AK. Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models. The Lancet Gastroenterology & Hepatology 2022;7:186-95. [DOI: 10.1016/s2468-1253(21)00191-6] [Reference Citation Analysis]
190 Kalal C, Benjamin J, Shasthry V, Kumar G, Sharma MK, Joshi YK, Sarin SK. Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial. Indian J Gastroenterol 2022. [PMID: 35235198 DOI: 10.1007/s12664-021-01187-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Zhao X, Li L, Zhou M, Liu M, Deng Y, He L, Guo C, Li Y. An Overview of the Mechanism of Penthorum chinense Pursh on Alcoholic Fatty Liver. Evid Based Complement Alternat Med 2020;2020:4875764. [PMID: 33014105 DOI: 10.1155/2020/4875764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants (Basel) 2021;10:364. [PMID: 33670839 DOI: 10.3390/antiox10030364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
193 Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology 2021;73:571-85. [PMID: 32246544 DOI: 10.1002/hep.31256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
194 [DOI: 10.1101/2020.07.14.203166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Zarinsefat A, Shui A, Stock P. Considerations For Use of Propensity Score Matching in Specific Patient Populations-Reply. JAMA Surg 2022. [PMID: 35544197 DOI: 10.1001/jamasurg.2022.1496] [Reference Citation Analysis]
196 Schreiner AD, Rockey DC. Evaluation of abnormal liver tests in the adult asymptomatic patient. Current Opinion in Gastroenterology 2018;34:272-9. [DOI: 10.1097/mog.0000000000000447] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
197 Song Y, Wu X, Yang D, Fang F, Meng L, Liu Y, Cui W. Protective Effect of Andrographolide on Alleviating Chronic Alcoholic Liver Disease in Mice by Inhibiting Nuclear Factor Kappa B and Tumor Necrosis Factor Alpha Activation. Journal of Medicinal Food 2020;23:409-15. [DOI: 10.1089/jmf.2019.4471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Abdallah MA, Singal AK. Editorial: biomarkers to optimise and personalise corticosteroid use among patients with severe alcoholic hepatitis-the search continues. Aliment Pharmacol Ther 2019;50:462-3. [PMID: 31359479 DOI: 10.1111/apt.15399] [Reference Citation Analysis]
199 Pirola CJ, Sookoian S. Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Aliment Pharmacol Ther 2018;48:773-5. [PMID: 30246305 DOI: 10.1111/apt.14901] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
200 Webel AR, Schexnayder J, Cioe PA, Zuñiga JA. A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science. J Assoc Nurses AIDS Care 2021;32:322-46. [PMID: 33595986 DOI: 10.1097/JNC.0000000000000240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Cheung A, Figueredo C, Rinella ME. Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients. Am J Gastroenterol 2019;114:579-90. [PMID: 30839326 DOI: 10.14309/ajg.0000000000000058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
202 Liu M, Huang Q, Zhu Y, Chen L, Li Y, Gong Z, Ai K. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100215] [Reference Citation Analysis]
203 Wang WJ, Xiao P, Xu HQ, Niu JQ, Gao YH. Growing burden of alcoholic liver disease in China: A review. World J Gastroenterol 2019; 25(12): 1445-1456 [PMID: 30948908 DOI: 10.3748/wjg.v25.i12.1445] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
204 Singal AK, Bailey SM. Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease. Gene Expr 2018;19:49-60. [PMID: 30086817 DOI: 10.3727/105221618X15325235888914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
205 Li W, Liang J, An J, Liu L, Hou Y, Li L, Zhao W, Cui L, Xue N, Al-dhamin Z, Han T, Nan Y, Zhang L, Granito A. Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-11. [DOI: 10.1155/2022/7395506] [Reference Citation Analysis]
206 Ge Y, Sun H, Xu L, Zhang W, Lv J, Chen Y. The amelioration of alcohol-induced liver and intestinal barrier injury by Lactobacillus rhamnosus Gorbach-Goldin (LGG) is dependent on Interleukin 22 (IL-22) expression. Bioengineered 2022;13:12650-60. [DOI: 10.1080/21655979.2022.2070998] [Reference Citation Analysis]
207 Shen NT, Salajegheh A, Brown RS. A call to standardize definitions, data collection & outcome assessment to improve care in alcohol-related liver disease. Hepatology. 2019;. [PMID: 30802988 DOI: 10.1002/hep.30587] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
208 LeWitt TM, Farshchian M, Grant-Kels JM, Daveluy S. Ethics of skin cancer treatment in a patient who continues with indoor tanning. J Am Acad Dermatol 2021:S0190-9622(21)02750-X. [PMID: 34752822 DOI: 10.1016/j.jaad.2021.10.057] [Reference Citation Analysis]
209 Sehrawat TS, Liu M, Shah VH. The knowns and unknowns of treatment for alcoholic hepatitis. Lancet Gastroenterol Hepatol 2020;5:494-506. [PMID: 32277902 DOI: 10.1016/S2468-1253(19)30326-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
210 Zhang Y, Jiang M, Cui BW, Jin CH, Wu YL, Shang Y, Yang HX, Wu M, Liu J, Qiao CY, Zhan ZY, Ye H, Zheng GH, Jin Q, Lian LH, Nan JX. P2X7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage-hepatocyte crosstalk. Br J Pharmacol 2020;177:2793-811. [PMID: 32022249 DOI: 10.1111/bph.15007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
211 Lee HS, Nagra N, La Selva D, Kozarek RA, Ross A, Weigel W, Beecher R, Chiorean M, Gluck M, Boden E, Venu N, Krishnamoorthi R, Larsen M, Lin OS. Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate. Clin Gastroenterol Hepatol 2021;19:180-8. [PMID: 32931961 DOI: 10.1016/j.cgh.2020.09.018] [Reference Citation Analysis]
212 Wu T, Morgan TR, Klein AS, Volk ML, Saab S, Sundaram V. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol 2018;17:759-68. [PMID: 30145578 DOI: 10.5604/01.3001.0012.3134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
213 Pi A, Jiang K, Ding Q, Lai S, Yang W, Zhu J, Guo R, Fan Y, Chi L, Li S. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice. Front Pharmacol 2021;12:752148. [PMID: 34603062 DOI: 10.3389/fphar.2021.752148] [Reference Citation Analysis]
214 Sak JJ, Prystupa A, Kiciński P, Luchowska-Kocot D, Kurys-Denis E, Bis-Wencel H. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis. World J Hepatol 2021; 13(12): 2071-2080 [DOI: 10.4254/wjh.v13.i12.2071] [Reference Citation Analysis]
215 Godfrey EL, Stribling R, Rana A. Liver Transplantation for Alcoholic Liver Disease: An Update. Clin Liver Dis 2019;23:127-39. [PMID: 30454827 DOI: 10.1016/j.cld.2018.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
216 Chernyavsky S, Dharapak P, Hui J, Laskova V, Merrill E, Pillay K, Siau E, Rizk D. Alcohol and the Hospitalized Patient. Med Clin North Am 2020;104:681-94. [PMID: 32505260 DOI: 10.1016/j.mcna.2020.02.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Rumbolt C, Minuk GY. The effects of binge drinking on healthy and diseased livers. CanLivJ 2021;4:93-8. [DOI: 10.3138/canlivj-2020-0037] [Reference Citation Analysis]
218 Yoon EL, Kim TY, Song DS, Kim HY, Kim CW, Jung YK, Sinn DH, Jang JY, Kim MY, Jeong SW, Kim SG, Suk KT, Kim DJ, Liver Failure KACLiF Study Group OBOTKA. The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients. J Clin Med 2019;8:E1600. [PMID: 31623316 DOI: 10.3390/jcm8101600] [Reference Citation Analysis]
219 Liu H, Liu H, Zhu L, Zhang Z, Zheng X, Liu J, Fu X. Comparative Transcriptome Analyses Provide Potential Insights into the Molecular Mechanisms of Astaxanthin in the Protection against Alcoholic Liver Disease in Mice. Mar Drugs 2019;17:E181. [PMID: 30893931 DOI: 10.3390/md17030181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
220 Choudhary NS, Duseja A. Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). Transl Gastroenterol Hepatol 2021;6:2. [PMID: 33409397 DOI: 10.21037/tgh.2019.09.06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
221 Jiang J, Tan Y, Liu A, Yan R, Ma Y, Guo L, Sun J, Guo Z, Fan H. Tissue engineered artificial liver model based on viscoelastic hyaluronan-collagen hydrogel and the effect of EGCG intervention on ALD. Colloids Surf B Biointerfaces 2021;206:111980. [PMID: 34293578 DOI: 10.1016/j.colsurfb.2021.111980] [Reference Citation Analysis]
222 Sun L, Wen S, Li Q, Lai X, Chen R, Zhang Z, Li D, Sun S. L-theanine relieves acute alcoholic liver injury by regulating the TNF-α/NF-κB signaling pathway in C57BL/6J mice. Journal of Functional Foods 2021;86:104699. [DOI: 10.1016/j.jff.2021.104699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
223 Yoon YH, Chen CM, Slater ME, Jung MK, White AM. Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018. Am J Prev Med 2020;59:469-80. [PMID: 32863077 DOI: 10.1016/j.amepre.2020.04.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Kumar R, Goh BG, Kam JW, Chang PE, Tan CK. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma. Clin Mol Hepatol 2020;26:196-208. [PMID: 31914720 DOI: 10.3350/cmh.2019.0012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
225 Yan Y, Ren L, Liu Y, Liu L. Long non-coding RNA CRNDE as potential biomarkers facilitate inflammation and apoptosis in alcoholic liver disease. Aging (Albany NY) 2021;13:23233-44. [PMID: 34633988 DOI: 10.18632/aging.203614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Meroni M, Longo M, Dongiovanni P. Alcohol or Gut Microbiota: Who Is the Guilty? Int J Mol Sci. 2019;20. [PMID: 31540133 DOI: 10.3390/ijms20184568] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
227 Zhang Y, Fan Y, He W, Han Y, Bao H, Yang R, Wang B, Kong D, Wang H. Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease. Cell Biosci 2021;11:148. [PMID: 34321090 DOI: 10.1186/s13578-021-00664-8] [Reference Citation Analysis]
228 Gallegos-Orozco JF. The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States. Am J Gastroenterol 2019;114:1712-3. [PMID: 31658103 DOI: 10.14309/ajg.0000000000000422] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
230 Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020;73:202-9. [PMID: 32278004 DOI: 10.1016/j.jhep.2020.03.039] [Cited by in Crossref: 726] [Cited by in F6Publishing: 626] [Article Influence: 363.0] [Reference Citation Analysis]
231 Abu Omar Y, Randhawa T, Attar B, Agrawal R, Wang Y, Pichardo R, Majeed MB, Patel SA. Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis. Cureus. 2019;11:e6141. [PMID: 31886076 DOI: 10.7759/cureus.6141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
232 Shipley LC, Kodali S, Singal AK. Recent updates on alcoholic hepatitis. Dig Liver Dis 2019;51:761-8. [PMID: 31010745 DOI: 10.1016/j.dld.2019.03.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
233 Huang H, Lin Z, Zeng Y, Lin X, Zhang Y. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model.Exp Ther Med. 2019;18:4733-4739. [PMID: 31777560 DOI: 10.3892/etm.2019.8123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
234 Strathearn LS, Stepanov AI, Font-Burgada J. Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020;12:E933. [PMID: 32230953 DOI: 10.3390/nu12040933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
235 Styskel B, Natarajan Y, Kanwal F. Nutrition in Alcoholic Liver Disease. Clinics in Liver Disease 2019;23:99-114. [DOI: 10.1016/j.cld.2018.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
236 Rodríguez M, González-Diéguez ML, Varela M, Cadahía V, Andrés-Vizán SM, Mesa A, Castaño A, Alvarez-Navascués C. Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis. Am J Gastroenterol 2021. [PMID: 34569986 DOI: 10.14309/ajg.0000000000001399] [Reference Citation Analysis]
237 Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A, Weber S, Matei AE, Chen CW, Maier C, Karouzakis E, Kiener HP, Pachera E, Dees C, Beyer C, Daniel C, Gelse K, Kremer AE, Naschberger E, Stürzl M, Butter F, Sticherling M, Finotto S, Kreuter A, Kaplan MH, Jüngel A, Gay S, Nutt SL, Boykin DW, Poon GMK, Distler O, Schett G, Distler JHW, Ramming A. PU.1 controls fibroblast polarization and tissue fibrosis. Nature 2019;566:344-9. [PMID: 30700907 DOI: 10.1038/s41586-019-0896-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
238 Zhang L, Wang Y, Xu Q, Zhang W, Liang H, Wu L, Ni L, Gao G, Yang D, Zhao H, Xiao J. Stroke among highly active antiretroviral therapy-naive people living with the human immunodeficiency virus in China: a retrospective study of the characteristics, risk factors, and prognosis. BMC Infect Dis 2022;22:4. [PMID: 34983408 DOI: 10.1186/s12879-021-06989-6] [Reference Citation Analysis]
239 Peeraphatdit TB, Kamath PS, Karpyak VM, Davis B, Desai V, Liangpunsakul S, Sanyal A, Chalasani N, Shah VH, Simonetto DA. Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020;18:477-485.e5. [PMID: 31042580 DOI: 10.1016/j.cgh.2019.04.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
240 Nagaoki Y, Hyogo H, Ando Y, Kosaka Y, Uchikawa S, Nishida Y, Teraoka Y, Morio K, Fujino H, Ono A, Nakahara T, Murakami E, Yamauchi M, Okamoto W, Kawaoka T, Tsuge M, Hiramatsu A, Miki D, Imamura M, Takahashi S, Chayama K, Aikata H. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study. BMC Gastroenterol 2021;21:306. [PMID: 34332532 DOI: 10.1186/s12876-021-01884-5] [Reference Citation Analysis]
241 Peeraphatdit TB, Ahn JC, Choi DH, Allen AM, Simonetto DA, Kamath PS, Shah VH. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Mayo Clin Proc 2020;95:2612-20. [PMID: 33276835 DOI: 10.1016/j.mayocp.2020.04.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Sharma P, Arora A. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. Transl Gastroenterol Hepatol 2020;5:19. [PMID: 32258523 DOI: 10.21037/tgh.2019.10.02] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
243 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Reference Citation Analysis]
244 Barros-Santos T, Libarino-Santos M, Anjos-Santos A, Lins JF, Leite JPC, Pacheco RC, Nascimento-Rocha V, Kisaki ND, Tamura EK, Oliveira-Lima AJ, Berro LF, Uetanabaro APT, Nicoli JR, Marinho EAV. Sex differences in the development of conditioned place preference induced by intragastric alcohol administration in mice. Drug Alcohol Depend 2021;229:109105. [PMID: 34628094 DOI: 10.1016/j.drugalcdep.2021.109105] [Reference Citation Analysis]
245 Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA 2021;326:165-76. [PMID: 34255003 DOI: 10.1001/jama.2021.7683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Ibars M, Maier MT, Yulyaningsih E, Perez L, Cheang R, Vilhelmsson A, Louie SM, Wegner SA, Yuan X, Eltzschig HK, Hopf FW, Nomura DK, Koliwad SK, Xu AW. Neuronal modulation of hepatic lipid accumulation induced by bingelike drinking. Am J Physiol Endocrinol Metab 2020;318:E655-66. [PMID: 32045262 DOI: 10.1152/ajpendo.00218.2019] [Reference Citation Analysis]